Teva wins FDA approval for Huntington's drug

(Reuters) - Israel-based Teva Pharmaceutical Industries Ltd said the U.S. Food and Drug Administration had approved its drug to treat chorea stemming from Huntington's disease, a fatal degenerative disorder.